This guideline covers diagnosing and managing varicose veins in people aged 18 and over.
Few of the more than 90 million Americans with obesity are seeking and receiving long-term obesity care, according to new...
Aethoxysklerol is indicated for sclerotherapy of varicose veins of the lower extremities.
Obesity remains the most important risk factor for the incidence and progression of osteoarthritis (OA). The leading cause of OA was believed to be overloading the joints due to excess weight which in turn leads to the destruction of articular cartilage
Purpose of review: Obesity is a major risk factor for the development of de novo chronic kidney disease (CKD). However, once kidney disease is acquired, obesity is paradoxically linked with greater survival, especially in those with advanced CKD.
Areas covered: Herein, the authors review the most commonly used FDA approved medications for the treatment of obesity, describing their mechanism of action, and the efficacy and safety of the medications as seen in...
ACTION (Awareness, Care, and Treatment in Obesity maNagement) examined obesity-related perceptions, attitudes, and behaviors among people with obesity (PwO), health care providers (HCPs), and employer representatives (ERs).
We performed a systematic review and meta-analysis of the effects of obesity ± overweight and weight loss on the corrected...